This record was last updated December 11, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the efficacy of topical 2.5% hydrocortisone in TMJ arthralgia. The main questions it aims to answer are:
* How does pain reduction compare?
* How does improvement in jaw function limitation compare?
* How do side effects compare? Participants will
* On day 1 be examined and report their pain level and jaw function limitation
* On days 1-21, apply their cream four times a day
* On day 21, report their pain level, jaw function limitation, compliance with instructions, and side effects.
Researchers will compare topical 2.5% hydrocortisone and topical 1% diclofenac to see if efficacy and side effects differ.
Protocol Amendment History
3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-04-03; most recent amendment 2024-12-05.
Status change: Not Yet Recruiting → Recruiting2023-10-11